ReCyte Therapeutics and OncoCyte Corporation Release: BioTime (BTX) Licenses Technology for Key Regulatory Gene Underlying Cancer and Stem Cell Reprogramming from The Wistar Institute
1/24/2012 6:55:12 AM
More...
|
Melanoma Patients Offered New Hope with Drug Combos, The Wistar Institute Study
12/17/2010 7:25:18 AM
More...
|
One Company, The Wistar Institute, Aims to Re-purpose a Smallpox Vaccine to Battle HIV
8/24/2010 6:55:20 AM
More...
|
"New" Human Adenovirus May Not Make for Good Vaccines, After All AdHu26 Demonstrates Same Fault as Previously Studied Vaccine Vectors, The Wistar Institute Study
8/12/2010 6:41:33 AM
More...
|
Gene Alteration Enables Mice To Rapidly Heal Wounds, The Wistar Institute Study
3/30/2010 7:38:22 AM
More...
|
One Gene Lost = One Limb Regained? The Wistar Institute Scientists Demonstrate Mammalian Regeneration Through a Single Gene Deletion
3/16/2010 7:48:23 AM
More...
|
Nikon Instruments Inc. And The Wistar Institute Present Small World Exhibition And Microscopy Seminars
1/20/2010 1:52:27 PM
More...
|
Gene That Regulates Breast Cancer Metastasis Identified At The Wistar Institute
10/7/2009 7:17:19 AM
More...
|
Scientists At The Wistar Institute Identify Novel Inhibitor Of Human MicroRNA
9/25/2008 5:39:14 PM
More...
|
Researchers at The Wistar Institute Invigorate 'Exhausted' Immune Cells
9/18/2008 4:23:25 PM
More...
|
|